These two biotechs only have one marketable therapy each, but both have blockbuster potential.
DALLAS, TX, UNITED STATES, February 14, 2026 /EINPresswire.com/ — Andrew Hillman announces the launch of the Andrew Hillman ...
As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...
Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.
NINGBO, ZHEJIANG, CHINA, January 21, 2026 /EINPresswire.com/ -- Ningbo Scientz Biotechnology Co., Ltd., a leading ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Vinay Prasad is tightening the screws at the FDA, overruling staff and signaling a tougher stance on vaccines and gene ...
AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...
Legend Biotech (NASDAQ:LEGN) is one of the 17 biotechnology stocks with more than 50% upside. On January 20, Leonid Timashev ...
SHANDONG, SHANDONG, CHINA, January 28, 2026 /EINPresswire.com/ -- In the rapidly evolving world of pet care, where "pet ...
2026 could be a big year for this company.
Two biotechs take full floors at Waltham’s GENESIS 21 Hickory — about 48K sq ft added to the Route 128 lab campus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results